AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
The interim phase 2 trial results show a good immune response in participants and the therapy is well tolerated to date.
Dexys Midnight Runners founding member Andy Leek has died aged 66 after a battle with Parkinson's disease. He died on ...
From swollen ankles to a persistent cough, these 5 subtle signs could reveal you are at risk of heart failure long before you ...
The 78-year-old broadcaster lifted the lid on how he has been coping with the health news, as well as sharing his opinion on ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...
Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...